Key statistics
As of last trade Barinthus Biotherapeutics PLC (2AB:STU) traded at 0.58, 4.50% above its 52-week low of 0.555, set on Apr 14, 2025.
52-week range
| Open | 0.57 |
|---|---|
| High | 0.590 |
| Low | 0.565 |
| Bid | 0.58 |
| Offer | 0.62 |
| Previous close | 0.590 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 40.83m |
| Free float | 37.52m |
| P/E (TTM) | -- |
| Market cap | 28.89m USD |
| EPS (TTM) | -1.88 USD |
Data delayed at least 15 minutes, as of Feb 09 2026.
More ▼
Announcements
- Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
- Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
- Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
- Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
- Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
- Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
- Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
More ▼
